XML 94 R39.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The following table presents certain financial data for the Company’s reportable segment (in thousands):
December 31,
20252024
Clinical trial expenses $9,602 $15,892 
Employee related research and development expenses8,915 8,560 
Chemistry, manufacturing and controls expenses1,896 4,260 
Other research and development expenses5,248 5,971 
Contract and grant reimbursements(754)(1,027)
Employee related general and administrative expenses5,506 3,682 
Professional fees and other general and administrative expenses 7,300 7,648 
Other segment items 1,858 6,912 
Segment net loss$39,571 $51,898 
Total segment assets$25,862 $28,178